Regulation 8 Amendment to regulation 250
In regulation 250 (exceptions to regulation 249)f1, after paragraph (4A) insert—
“(4B)A person may, in the course of a business consisting (wholly or partly) of manufacturing medicinal products, or of selling products by way of wholesale dealing, sell or supply by way of wholesale dealing a naloxone product that is a prescription only medicine to—
(a)providers of drug treatment services that have arrangements as mentioned in regulation 237A(2)(a);
(b)the medical services of His Majesty’s forces;
(c)the bodies mentioned in regulation 237A(2)(c); and
(d)local naloxone providers.”.
Annotations
Footnotes
- f1
-
Amended by S.I. 2020/1125 (S.R. 2020/349).